Biocompatibility Innovation (BCI) is a pioneer in the development of biostealth technology for medical devices and life support equipment.
BCI's biostealth technology is precision designed to increase the biocompatibility of medical devices, prolonging their lifespan and increasing their durability, all while maintaining full device functionality.
BCI's rapidly scalable and regulatory-friendly technology utilizes pharmaceutical grade, plant-based active molecules to protect the prosthetic materials – polymers, metals, alloys, and biologic tissues – used in the manufacturing of medical devices.
Founded by a team of scientists and biotech industry executives, BCI partners with medical device manufacturers to bring its disruptive technology to market.
Company Details
- Employees
- 10
- Founded
- -
- Address
- Via Lorenzo De Antoni 17, Este (Pd),italy 35042,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Medical Devices, Coatings and Treatment, Biostealth Technologies, Anti-Infective Technologies, Anti-Inflammatory Technologies, Antithrombotic Technologies, Medtech, Biotech, Research and Innovation, Material Science.
- HQ
- Este (PD), ITALY
Biocompatibility Innovation Questions
Biocompatibility Innovation's website is https://bci-biocompatibility.com/
Biocompatibility Innovation's LinkedIn profile is https://it.linkedin.com/company/bci-biocompatibility-innovation
Biocompatibility Innovation has
10 employees.
View email and phone details for 10
employees at Biocompatibility Innovation.
Biocompatibility Innovation's industry is
Biotechnology Research
Biocompatibility Innovation's top competitors are
Bioactiva,
Pedon S.p.a.,
Aethera Biotech,
Fidia Pharma,
Ab Analitica,
Abr - Active Botanicals Research,
Aileens Pharma,
Zeta Farmaceutici Group,
Diamante Società Benefit Srl,
Biocompatibility Hub.
Biocompatibility Innovation's categories are Biotechnology Research
Biocompatibility Innovation's founding year is 2014
